Determine Sun Protection Factor of Mamaearth Vitamin C Daily Glow Sunscreen SPF 50

An in-Vivo Study to Determine the Sun Protection Factor of Mamaearth Vitamin C Daily Glow Sunscreen SPF 50 - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2024/07/071526

Enrollment

Registered

2024-07-29

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Mamaearth Vitamin C Daily Glow Sunscreen SPF 50: Quantity2 mg/sq.cm Route of administration: Topical Frequency: Once Duration: 1 hour Control Intervention1: Not Applicable: Not Appli

Eligibility

Inclusion criteria

Inclusion criteria: 1. Voluntary man or women between 18 and 65 years. 2. Photo type III to V. 3. Having apparently healthy skin on test area 4. For whom the investigator considers that the compliance will be correct. 5. Cooperating, informed of the need and duration of the examinations and ready to comply with protocol procedures. 6. Having signed a Consent Form. 7. Willingness to avoid intense UV exposure on test site (sun or artificial UV) during the course of the study. 8. Willingness to avoid excessive water contact (for example swimming) or activity which causes excessive sweating (that is exercise, sauna), during the course of the study. 9. Should be able to read and write (in English, Hindi or local language). 10. Having valid proof of identity and age.

Exclusion criteria

Exclusion criteria: 1. Pregnant or nursing mothers 2.Scars, excessive terminal hair or tattoo on the studied area 3.Henna tattoo anywhere on the body (in case of studies involving hair dyes) 4.Dermatological infection or pathology on the level of studied area 5.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye) 6.Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures 7.Chronic illness which may influence the outcome of the study 8.Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month) 9.Subject in an exclusion period or participating in another food, cosmetic or therapeutic trial.

Design outcomes

Primary

Measure	Time frame
Change in Individual MED (iMED) scoreTimepoint: Day 1 and Day 2	—

Secondary

Measure	Time frame
Change in the redness of skin Delayed Erythema ResponseTimepoint: Day 1, Day 2	—

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org8937015757

Outcome results